News on Wellness

HIV Prevention Drug Truvada Faces Criticism By Gay Men


A lifesaver drug for those infected by HIV is now caught under widespread debate among gay men. The Truvada conundrum produced by California-based Gilead Sciences has been hailed by AIDS activists and health professionals over its potentiality in protecting men engaging in gay sex without using condoms.
Doctors and activists have been campaigning hard in raising awareness about the preventive use of Truvada and reducing new HIV infections, but some are saying the efforts are reckless.

About 50,000 new cases of HIV infection are registered each year in the US.

Critics of the new drug says it tempts some of the condom users to abandon this layer of protection and hence are likely to get exposed to array of other sexuality transmitted infections.

Truvada has been around for about a decade. It is used in combination with other drugs for the treatment of people suffering from HIV. In 2012 the US Food and Drug Administration (FDA) approved it for pre-exposure prophylaxis, or PrEP to use it as a preventive measure from getting infected.

The drug is expensive. Its once-a-day regimen costs around $13,000 a year. However, most of the insurance plans cover prescriptions for it.

It is blue-colored pill and studies say if taken diligently it can reduce the risk of getting infected with HIV by more than 90 percent.

The US Centers for Disease Control and Prevention offers detailed information about the drug on their website.

Leave a Reply

Your email address will not be published. Required fields are marked *